Go Pro

111 Capital Acquires Shares of 9,431 Agilent Technologies, Inc. $A

Agilent Technologies logo with Healthcare background
Image from MarketBeat Media, LLC.

111 Capital bought a new stake in Agilent Technologies, Inc. (NYSE:A - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 9,431 shares of the medical research company's stock, valued at approximately $1,253,000.

A number of other institutional investors and hedge funds also recently made changes to their positions in A. Norges Bank bought a new position in Agilent Technologies during the 4th quarter worth approximately $549,158,000. AQR Capital Management LLC raised its stake in Agilent Technologies by 424.1% during the 2nd quarter. AQR Capital Management LLC now owns 2,041,826 shares of the medical research company's stock worth $240,956,000 after buying an additional 1,652,244 shares during the period. Ameriprise Financial Inc. raised its stake in Agilent Technologies by 132.2% during the 2nd quarter. Ameriprise Financial Inc. now owns 2,354,111 shares of the medical research company's stock worth $277,807,000 after buying an additional 1,340,161 shares during the period. Balyasny Asset Management L.P. lifted its holdings in Agilent Technologies by 192.0% during the fourth quarter. Balyasny Asset Management L.P. now owns 1,412,535 shares of the medical research company's stock worth $192,204,000 after acquiring an additional 928,821 shares in the last quarter. Finally, SG Americas Securities LLC lifted its holdings in Agilent Technologies by 107.2% during the first quarter. SG Americas Securities LLC now owns 1,674,856 shares of the medical research company's stock worth $190,900,000 after acquiring an additional 866,641 shares in the last quarter.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on A. Piper Sandler began coverage on Agilent Technologies in a report on Thursday, June 11th. They issued a "neutral" rating and a $150.00 price target for the company. HSBC cut their price objective on Agilent Technologies from $180.00 to $165.00 and set a "buy" rating on the stock in a report on Wednesday, June 3rd. Morgan Stanley boosted their price objective on Agilent Technologies from $160.00 to $175.00 and gave the company an "overweight" rating in a research report on Wednesday. Weiss Ratings raised Agilent Technologies from a "hold (c-)" rating to a "hold (c)" rating in a research note on Tuesday, June 2nd. Finally, Robert W. Baird raised their target price on shares of Agilent Technologies from $155.00 to $156.00 and gave the stock an "outperform" rating in a report on Tuesday, May 26th. Two investment analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $160.24.

Get Our Latest Stock Report on A

Agilent Technologies Stock Down 0.5%

Agilent Technologies stock opened at $148.55 on Friday. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.10 and a quick ratio of 1.62. The company's 50-day moving average is $135.38 and its 200-day moving average is $125.56. The firm has a market capitalization of $41.95 billion, a PE ratio of 29.83, a P/E/G ratio of 2.63 and a beta of 1.25. Agilent Technologies, Inc. has a fifty-two week low of $108.35 and a fifty-two week high of $160.27.

Agilent Technologies (NYSE:A - Get Free Report) last issued its earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.41 by $0.08. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The business had revenue of $1.83 billion during the quarter, compared to the consensus estimate of $1.80 billion. During the same period last year, the business posted $1.31 EPS. Agilent Technologies's revenue was up 10.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Sell-side analysts anticipate that Agilent Technologies, Inc. will post 6.03 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, July 22nd. Shareholders of record on Tuesday, June 30th were issued a dividend of $0.255 per share. The ex-dividend date of this dividend was Tuesday, June 30th. This represents a $1.02 annualized dividend and a yield of 0.7%. Agilent Technologies's dividend payout ratio (DPR) is currently 20.48%.

Agilent Technologies Profile

(Free Report)

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company's product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.

Featured Stories

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A - Free Report).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Agilent Technologies Right Now?

Before you consider Agilent Technologies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agilent Technologies wasn't on the list.

While Agilent Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines